ARID1A and gastric cancer: In the TCGA cohort, gastric cancer (GC) harboring variants in RECQL4, ARID1A, MAGI1, or JAK3 were 4.5% (n = 20), 27.0% (n = 119), 7.5% (n = 33), or 3.8% (n = 17), respectively.